{"gene":"GADD45GIP1","run_date":"2026-04-28T17:46:04","timeline":{"discoveries":[{"year":2001,"finding":"GADD45GIP1 (then called CKBBP2) was identified as a binding partner of the CKIIβ regulatory subunit via yeast two-hybrid assay. The minimal binding region on CKIIβ for CKBBP2 was mapped to residues 67–130, distinct from binding sites for other CKIIβ interactors.","method":"Yeast two-hybrid mapping with truncation constructs; overlay (far-western) experiments","journal":"Molecules and cells","confidence":"Medium","confidence_rationale":"Tier 3 — single yeast two-hybrid study with domain mapping, single lab","pmids":["11710515"],"is_preprint":false},{"year":2006,"finding":"GADD45GIP1 (CKBBP2/CRIF1) physically associates with the CKIIβ subunit and is phosphorylated by protein kinase CKII at serine-221. Phosphomimetic mutation S221E promotes cell proliferation, whereas the non-phosphorylatable S221A mutant does not, establishing CKII-mediated phosphorylation of GADD45GIP1 as a positive regulator of cell proliferation.","method":"Yeast two-hybrid, GST pull-down, in vitro kinase assay with recombinant CKII, phosphoamino acid analysis, site-directed mutagenesis (S221A and S221E), cell proliferation assay in COS7 cells","journal":"Gene","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro kinase assay with mutagenesis and functional proliferation readout in cells, multiple orthogonal methods in one study","pmids":["17069992"],"is_preprint":false},{"year":2007,"finding":"NAC-1, a BTB/POZ transcription repressor, negatively regulates GADD45GIP1 transcription. NAC-1 knockdown in SKOV3 and HeLa cells induces GADD45GIP1 expression, while NAC-1 overexpression in NAC-1-negative cells suppresses it. Ectopic GADD45GIP1 expression causes growth arrest in tumor cells in vitro and in vivo, and partial rescue of dominant-negative NAC-1-induced growth inhibition by GADD45GIP1 knockdown establishes GADD45GIP1 as a downstream tumor-suppressive effector of the NAC-1 pathway.","method":"Serial analysis of gene expression (SAGE), siRNA knockdown, ectopic overexpression, dominant-negative NAC-1, in vitro and in vivo (xenograft) growth assays","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (SAGE, KD, OE, in vivo), bidirectional epistasis demonstrated","pmids":["17804717"],"is_preprint":false},{"year":2009,"finding":"GADD45GIP1 interacts with GADD45γ (growth arrest and DNA-damage-inducible 45-gamma). Loss of GADD45GIP1 confers paclitaxel resistance in ovarian cancer cells, while ectopic GADD45GIP1 expression increases paclitaxel sensitivity. NAC-1 homodimerization suppresses the pathway; disruption of NAC-1 dimerization induces GADD45γ expression, which then interacts with GADD45GIP1, and GADD45γ knockdown partially restores paclitaxel resistance.","method":"shRNA knockdown, ectopic expression, dominant-negative BTB/POZ domain construct, ex vivo paclitaxel resistance assays, co-expression epistasis analysis","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — bidirectional genetic epistasis with multiple cancer cell lines and tissue validation; interaction with GADD45γ established","pmids":["19305429"],"is_preprint":false},{"year":2014,"finding":"The Drosophila ortholog of GADD45GIP1/CRIF1 (dCRIF) is required for RNAi efficiency and antiviral immunity. dCRIF loss-of-function mutants are deficient in siRNA biogenesis and RNAi-mediated knockdown. dCRIF physically interacts with and stabilizes the RNase III enzyme Dicer-2, identifying a conserved role for CRIF1 in regulating the RNAi machinery.","method":"Drosophila genetic screen, loss-of-function mutants, siRNA biogenesis assays, antiviral immunity assays, co-immunoprecipitation (dCRIF–Dicer-2 interaction)","journal":"RNA biology","confidence":"Medium","confidence_rationale":"Tier 2–3 — genetic KO with defined molecular phenotype and Co-IP for interaction, but Drosophila ortholog study","pmids":["25483042"],"is_preprint":false},{"year":2015,"finding":"Beta-cell-specific deletion of Crif1 (Gadd45gip1) in mice causes progressive mitochondrial oxidative phosphorylation (OxPhos) dysfunction leading to impaired insulin secretion and beta cell failure, demonstrating that CRIF1 is essential for the synthesis and assembly of OxPhos complexes in the inner mitochondrial membrane of beta cells.","method":"Conditional (beta-cell-specific) Crif1 knockout mouse model, glucose tolerance tests, insulin secretion assays, ultrastructural electron microscopy of mitochondria","journal":"Diabetologia","confidence":"High","confidence_rationale":"Tier 2 — clean in vivo conditional KO with defined cellular phenotype and ultrastructural validation","pmids":["25660120"],"is_preprint":false},{"year":2017,"finding":"NAC1 suppresses GADD45GIP1 expression and promotes cisplatin resistance in ovarian cancer cells by inhibiting cisplatin-induced cellular senescence. NAC1 knockdown increases GADD45GIP1 expression and enhances senescence-dependent cisplatin cytotoxicity, while NAC1 overexpression in NAC1-negative cells reduces cisplatin sensitivity, establishing the NAC1/GADD45GIP1 axis as a regulator of drug-induced senescence.","method":"RNA interference (siRNA/shRNA), ectopic overexpression, cisplatin cytotoxicity assays, cellular senescence assays (β-galactosidase staining) in SKOV3 and TOV-21G cells","journal":"Oncology letters","confidence":"Medium","confidence_rationale":"Tier 2–3 — bidirectional genetic manipulation with defined senescence phenotype, single lab","pmids":["28599472"],"is_preprint":false},{"year":2019,"finding":"CRM197, a specific HB-EGF inhibitor, reverses paclitaxel resistance in ovarian cancer cells by downregulating NAC-1, leading to upregulation of GADD45GIP1, which in turn activates the pro-apoptotic JNK/p38 MAPK pathway and increases caspase-3 activity. This positions GADD45GIP1 as a mediator linking NAC-1 suppression to apoptotic signaling.","method":"In vitro cell viability assays, in vivo xenograft models, Western blotting for NAC-1/GADD45GIP1/JNK/p38/caspase-3 pathway components","journal":"Cancer medicine","confidence":"Medium","confidence_rationale":"Tier 3 — pathway placement by expression/activity measurements in vitro and in vivo, no direct epistasis rescue","pmids":["31490008"],"is_preprint":false},{"year":2020,"finding":"Adipocyte-specific deletion of Crif1 (Gadd45gip1) reduces adipocyte OxPhos function, triggering the mitochondrial unfolded protein response and upregulating secretion of mitokines GDF15 and FGF21. These mitokines mediate systemic metabolic benefits including resistance to diet-induced obesity and improved glucose tolerance, demonstrating that CRIF1 in adipocytes regulates both cell-autonomous and non-cell-autonomous energy homeostasis via mitokine signaling.","method":"Adipocyte-specific Crif1 KO mice (AdKO), global Gdf15 and Fgf21 KO crosses (AdGKO, AdFKO), RNA sequencing, metabolic phenotyping (weight, EE, glucose tolerance), pharmacological OxPhos inhibition in 3T3L1 cells","journal":"Diabetologia","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with multiple orthogonal genetic crosses (AdGKO, AdFKO) establishing pathway hierarchy, replicated in vitro","pmids":["31925461"],"is_preprint":false},{"year":2025,"finding":"GADD45GIP1 physically interacts with RPL35 (ribosomal protein L35), identified by co-immunoprecipitation and LC-MS/MS proteomics. GADD45GIP1 stabilizes RPL35 by inhibiting its polyubiquitination and proteasomal degradation. RPL35 knockdown activates the PERK/eIF2α ER stress pathway, and RPL35 overexpression rescues the reduced cell viability caused by GADD45GIP1 knockdown, establishing GADD45GIP1 as a regulator of RPL35 stability that modulates ER stress in osteosarcoma.","method":"IP/LC-MS/MS proteomics, siRNA knockdown, overexpression, ubiquitination assay (polyubiquitination), Western blotting for PERK/eIF2α pathway, cell viability and migration assays in vitro and in vivo","journal":"Cancer cell international","confidence":"Medium","confidence_rationale":"Tier 2–3 — IP-MS interaction plus ubiquitination assay and rescue experiment, single lab with multiple methods","pmids":["40604925"],"is_preprint":false}],"current_model":"GADD45GIP1/CRIF1 is a multifunctional mitochondrial and nuclear protein: it is essential for the assembly and function of inner mitochondrial membrane oxidative phosphorylation complexes (demonstrated by tissue-specific KO models in beta cells and adipocytes); it is phosphorylated at Ser-221 by protein kinase CKII, promoting cell proliferation; it is transcriptionally repressed by the BTB/POZ factor NAC-1, and its re-expression causes growth arrest and sensitizes tumor cells to paclitaxel and cisplatin by suppressing drug-induced senescence and activating GADD45γ/JNK/p38/caspase-3 apoptotic signaling; and it stabilizes RPL35 against ubiquitin-mediated degradation to modulate ER stress via the PERK/eIF2α pathway."},"narrative":{"teleology":[{"year":2001,"claim":"Identification of GADD45GIP1 as a physical interactor of the CKIIβ regulatory subunit established it as a potential signaling target of the CKII kinase, opening the question of whether CKII phosphorylates it and with what functional consequence.","evidence":"Yeast two-hybrid screen and far-western overlay mapping the CKIIβ binding region","pmids":["11710515"],"confidence":"Medium","gaps":["Single yeast two-hybrid study without in vivo validation of the interaction","Phosphorylation and functional relevance not yet tested"]},{"year":2006,"claim":"Demonstration that CKII phosphorylates GADD45GIP1 at Ser-221 and that this modification promotes cell proliferation resolved the functional consequence of the CKII interaction, establishing GADD45GIP1 as a growth-regulatory phosphoprotein.","evidence":"In vitro kinase assay, phosphoamino acid analysis, S221A/S221E mutagenesis with proliferation readout in COS7 cells","pmids":["17069992"],"confidence":"High","gaps":["In vivo relevance of Ser-221 phosphorylation not tested","Downstream effectors of phospho-GADD45GIP1-driven proliferation not identified"]},{"year":2007,"claim":"Discovery that the BTB/POZ repressor NAC-1 transcriptionally silences GADD45GIP1, and that restoring GADD45GIP1 expression causes tumor growth arrest in vitro and in vivo, established GADD45GIP1 as a bona fide tumor-suppressive effector in the NAC-1 oncogenic pathway.","evidence":"SAGE, siRNA/overexpression epistasis, xenograft growth assays in SKOV3 and HeLa cells","pmids":["17804717"],"confidence":"High","gaps":["Mechanism by which GADD45GIP1 enforces growth arrest not defined","Whether NAC-1 directly binds the GADD45GIP1 promoter not shown"]},{"year":2009,"claim":"Linking GADD45GIP1 to GADD45γ interaction and showing that this axis mediates paclitaxel sensitivity upon disruption of NAC-1 dimerization revealed the downstream apoptotic effector mechanism through which GADD45GIP1 sensitizes tumor cells to chemotherapy.","evidence":"Bidirectional genetic epistasis (shRNA, ectopic expression, dominant-negative BTB domain) with paclitaxel resistance assays in ovarian cancer cells","pmids":["19305429"],"confidence":"High","gaps":["Structural basis of GADD45GIP1–GADD45γ interaction unknown","Whether GADD45GIP1 directly participates in MAPK cascade activation not resolved"]},{"year":2014,"claim":"Identification of the Drosophila ortholog dCRIF as essential for Dicer-2 stability and siRNA biogenesis broadened the functional repertoire of CRIF1 family proteins to include regulation of the RNAi machinery and antiviral defense.","evidence":"Drosophila genetic screen with loss-of-function mutants, siRNA biogenesis assays, co-immunoprecipitation of dCRIF–Dicer-2","pmids":["25483042"],"confidence":"Medium","gaps":["Conservation of the Dicer-2-stabilizing function in mammalian GADD45GIP1 not tested","Mechanism of stabilization (chaperone-like vs. stoichiometric protection) not determined"]},{"year":2015,"claim":"Beta-cell-specific Crif1 knockout demonstrated that GADD45GIP1 is essential for mitochondrial OxPhos complex assembly, resolving the primary cell-autonomous function of the protein in energy metabolism and linking its loss to beta cell failure and impaired insulin secretion.","evidence":"Conditional Crif1 KO mouse, glucose tolerance and insulin secretion assays, electron microscopy of mitochondrial ultrastructure","pmids":["25660120"],"confidence":"High","gaps":["Specific OxPhos complex subunits whose insertion depends on CRIF1 not individually mapped","Whether CRIF1 acts co-translationally at the mitoribosome or post-translationally not distinguished"]},{"year":2017,"claim":"Establishing that NAC1 promotes cisplatin resistance by suppressing GADD45GIP1 and thereby blocking drug-induced senescence expanded the tumor-suppressive role of GADD45GIP1 from paclitaxel to platinum-based chemotherapy and identified cellular senescence as a key effector phenotype.","evidence":"siRNA/shRNA and overexpression in SKOV3 and TOV-21G cells, cisplatin cytotoxicity and β-galactosidase senescence assays","pmids":["28599472"],"confidence":"Medium","gaps":["Single-lab study; independent replication in additional cell lines or models needed","Molecular mechanism linking GADD45GIP1 to senescence induction not defined"]},{"year":2019,"claim":"Placement of GADD45GIP1 as the mediator connecting NAC-1 downregulation (by CRM197) to JNK/p38 MAPK activation and caspase-3-dependent apoptosis completed the signaling cascade from NAC-1 repression through GADD45GIP1 to cell death.","evidence":"CRM197 treatment in vitro and in vivo xenograft models, Western blotting of NAC-1/GADD45GIP1/JNK/p38/caspase-3 pathway","pmids":["31490008"],"confidence":"Medium","gaps":["No direct epistasis rescue experiment to confirm GADD45GIP1 is required downstream of CRM197","Pathway placement relies on expression/activity correlations"]},{"year":2020,"claim":"Adipocyte-specific Crif1 deletion demonstrated that CRIF1 loss triggers the mitochondrial unfolded protein response and non-cell-autonomous metabolic benefits via GDF15 and FGF21 mitokine secretion, revealing a systemic endocrine signaling axis controlled by mitochondrial OxPhos fidelity.","evidence":"Adipocyte-specific Crif1 KO mice crossed with global Gdf15-KO and Fgf21-KO, RNA-seq, metabolic phenotyping, pharmacological OxPhos inhibition in 3T3-L1 cells","pmids":["31925461"],"confidence":"High","gaps":["Whether the metabolic benefit is durable long-term or represents a compensatory acute response is not fully resolved","Direct mechanism linking mitochondrial UPR to GDF15/FGF21 transcriptional activation not defined"]},{"year":2025,"claim":"Discovery that GADD45GIP1 stabilizes RPL35 by blocking its polyubiquitination and that RPL35 loss activates PERK/eIF2α ER stress uncovered a previously unrecognized function of GADD45GIP1 in ribosomal protein quality control and ER stress modulation.","evidence":"IP/LC-MS/MS proteomics, ubiquitination assays, siRNA knockdown and overexpression rescue, PERK/eIF2α Western blotting in osteosarcoma cells","pmids":["40604925"],"confidence":"Medium","gaps":["Single-lab study; awaits independent confirmation in non-cancer cell types","E3 ubiquitin ligase targeting RPL35 not identified","Relationship between GADD45GIP1's mitoribosomal role and its cytoplasmic RPL35-stabilizing function unclear"]},{"year":null,"claim":"Whether GADD45GIP1/CRIF1 acts co-translationally at the mitoribosome to insert OxPhos subunits versus as a post-translational chaperone, how its nuclear/cytoplasmic tumor-suppressive functions are coordinated with its mitochondrial role, and the structural basis for its diverse protein–protein interactions remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of GADD45GIP1 in context of the mitoribosome or any partner complex","Mechanism of dual localization (mitochondrial vs. nuclear) and how it is regulated is unknown","Whether the Dicer-2/RNAi role observed in Drosophila is conserved in mammals is untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,3,6,7,9]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[5,8]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[5,8]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,3]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[5,8]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[3,7]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,7]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[8,9]}],"complexes":["mitochondrial large ribosomal subunit (39S)"],"partners":["CSNK2B","GADD45G","NACC1","RPL35"],"other_free_text":[]},"mechanistic_narrative":"GADD45GIP1 (CRIF1/mL64) is a mitochondrial large ribosomal subunit protein essential for the synthesis and insertion of oxidative phosphorylation (OxPhos) complex subunits into the inner mitochondrial membrane, as demonstrated by conditional knockout models in pancreatic beta cells and adipocytes where its loss causes progressive OxPhos dysfunction, impaired insulin secretion, and compensatory mitokine (GDF15/FGF21) secretion that systemically improves energy homeostasis [PMID:25660120, PMID:31925461]. Beyond its mitochondrial role, GADD45GIP1 functions as a tumor-suppressive effector downstream of the transcriptional repressor NAC-1: its re-expression induces growth arrest, sensitizes ovarian cancer cells to paclitaxel and cisplatin by counteracting drug-induced senescence, and activates GADD45γ-dependent JNK/p38/caspase-3 apoptotic signaling [PMID:17804717, PMID:19305429, PMID:31490008]. GADD45GIP1 is phosphorylated by casein kinase II at Ser-221, and the phosphomimetic S221E mutant promotes cell proliferation, indicating context-dependent regulation of growth [PMID:17069992]. GADD45GIP1 also stabilizes the ribosomal protein RPL35 by inhibiting its polyubiquitination, thereby modulating PERK/eIF2α-mediated ER stress signaling [PMID:40604925]."},"prefetch_data":{"uniprot":{"accession":"Q8TAE8","full_name":"Large ribosomal subunit protein mL64","aliases":["39S ribosomal protein L59, mitochondrial","MRP-L59","CKII beta-associating protein","CR6-interacting factor 1","CRIF1","Growth arrest and DNA damage-inducible proteins-interacting protein 1","Papillomavirus L2-interacting nuclear protein 1","PLINP","PLINP-1","p53-responsive gene 6 protein"],"length_aa":222,"mass_kda":25.4,"function":"Acts as a negative regulator of G1 to S cell cycle phase progression by inhibiting cyclin-dependent kinases. Inhibitory effects are additive with GADD45 proteins but also occur in the absence of GADD45 proteins. Acts as a repressor of the orphan nuclear receptor NR4A1 by inhibiting AB domain-mediated transcriptional activity. May be involved in the hormone-mediated regulation of NR4A1 transcriptional activity. May play a role in mitochondrial protein synthesis","subcellular_location":"Mitochondrion; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8TAE8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GADD45GIP1","classification":"Not Classified","n_dependent_lines":277,"n_total_lines":1208,"dependency_fraction":0.2293046357615894},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CALM1","stoichiometry":0.2},{"gene":"CALM2","stoichiometry":0.2},{"gene":"CALM3","stoichiometry":0.2},{"gene":"LSM14A","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/GADD45GIP1","total_profiled":1310},"omim":[{"mim_id":"610672","title":"NUCLEUS ACCUMBENS-ASSOCIATED PROTEIN 1, BEN AND BTB/POZ DOMAINS-CONTAINING; NACC1","url":"https://www.omim.org/entry/610672"},{"mim_id":"605162","title":"GADD45G-INTERACTING PROTEIN; GADD45GIP1","url":"https://www.omim.org/entry/605162"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GADD45GIP1"},"hgnc":{"alias_symbol":["PLINP-1","MGC4667","MGC4758","CKBBP2","PRG6","Plinp1","CRIF1","CKbetaBP2","mL64"],"prev_symbol":[]},"alphafold":{"accession":"Q8TAE8","domains":[{"cath_id":"-","chopping":"51-93","consensus_level":"high","plddt":96.2884,"start":51,"end":93},{"cath_id":"-","chopping":"98-205","consensus_level":"medium","plddt":92.1642,"start":98,"end":205}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TAE8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TAE8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TAE8-F1-predicted_aligned_error_v6.png","plddt_mean":86.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GADD45GIP1","jax_strain_url":"https://www.jax.org/strain/search?query=GADD45GIP1"},"sequence":{"accession":"Q8TAE8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8TAE8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8TAE8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TAE8"}},"corpus_meta":[{"pmid":"19305429","id":"PMC_19305429","title":"NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway.","date":"2009","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19305429","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7677843","id":"PMC_7677843","title":"Use of reporter genes to identify recessive trans-acting mutations specifically involved in the regulation of Aspergillus nidulans penicillin biosynthesis genes.","date":"1995","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/7677843","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17804717","id":"PMC_17804717","title":"NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressor.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17804717","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31925461","id":"PMC_31925461","title":"An adipocyte-specific defect in oxidative phosphorylation increases systemic energy expenditure and protects against diet-induced obesity in mouse models.","date":"2020","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/31925461","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25660120","id":"PMC_25660120","title":"Disruption of CR6-interacting factor-1 (CRIF1) in mouse islet beta cells leads to mitochondrial diabetes with progressive beta cell failure.","date":"2015","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/25660120","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31490008","id":"PMC_31490008","title":"CRM197 reverses paclitaxel resistance by inhibiting the NAC-1/Gadd45 pathway in paclitaxel-resistant ovarian cancer cells.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31490008","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17069992","id":"PMC_17069992","title":"Phosphorylation of CKBBP2/CRIF1 by protein kinase CKII promotes cell proliferation.","date":"2006","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/17069992","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11710515","id":"PMC_11710515","title":"Mapping of the interaction domain of the protein kinase CKII beta subunit with target proteins.","date":"2001","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/11710515","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28599472","id":"PMC_28599472","title":"Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer.","date":"2017","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/28599472","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25483042","id":"PMC_25483042","title":"Requirement for CRIF1 in RNA interference and Dicer-2 stability.","date":"2014","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/25483042","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40604925","id":"PMC_40604925","title":"GADD45GIP1 promotes osteosarcoma progression by modulating RPL35 ubiquitination and alleviating endoplasmic reticulum stress via the PERK/eIF2α pathway.","date":"2025","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/40604925","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41606585","id":"PMC_41606585","title":"Unresolved questions on the GADD45GIP1-RPL35 axis in osteosarcoma: mechanistic links to ER stress and therapeutic targeting.","date":"2026","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/41606585","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21145461","id":"PMC_21145461","title":"Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21145461","citation_count":318,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25278503","id":"PMC_25278503","title":"Structure of the large ribosomal subunit from human mitochondria.","date":"2014","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/25278503","citation_count":262,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34800366","id":"PMC_34800366","title":"Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.","date":"2021","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34800366","citation_count":239,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17207965","id":"PMC_17207965","title":"hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17207965","citation_count":222,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27023846","id":"PMC_27023846","title":"Structure and Function of the Mitochondrial Ribosome.","date":"2016","source":"Annual review of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27023846","citation_count":217,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22453275","id":"PMC_22453275","title":"Mitochondrial nucleoid interacting proteins support mitochondrial protein synthesis.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/22453275","citation_count":173,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20186120","id":"PMC_20186120","title":"A functional peptidyl-tRNA hydrolase, ICT1, has been recruited into the human mitochondrial ribosome.","date":"2010","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/20186120","citation_count":153,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25900982","id":"PMC_25900982","title":"BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.","date":"2015","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/25900982","citation_count":149,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32877691","id":"PMC_32877691","title":"A High-Density Human Mitochondrial Proximity Interaction Network.","date":"2020","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32877691","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31871319","id":"PMC_31871319","title":"Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31871319","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29117863","id":"PMC_29117863","title":"RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination.","date":"2017","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/29117863","citation_count":135,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21832049","id":"PMC_21832049","title":"Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21832049","citation_count":131,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32989298","id":"PMC_32989298","title":"PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase.","date":"2020","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/32989298","citation_count":129,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15231747","id":"PMC_15231747","title":"A protein interaction framework for human mRNA degradation.","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15231747","citation_count":123,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25187353","id":"PMC_25187353","title":"Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25187353","citation_count":123,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35140242","id":"PMC_35140242","title":"Human transcription factor protein interaction networks.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35140242","citation_count":123,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25609649","id":"PMC_25609649","title":"Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.","date":"2015","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/25609649","citation_count":120,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31753913","id":"PMC_31753913","title":"Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/31753913","citation_count":110,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7859,"output_tokens":2718,"usd":0.032174},"stage2":{"model":"claude-opus-4-6","input_tokens":6049,"output_tokens":3016,"usd":0.158468},"total_usd":0.415044,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":19241,"output_tokens":3515,"usd":0.055224},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6632,"output_tokens":3185,"usd":0.169178}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"GADD45GIP1 is transcriptionally repressed by NAC-1 (a BTB/POZ transcription repressor); NAC-1 knockdown induces GADD45GIP1 expression, while engineered NAC-1 expression suppresses it. Induced GADD45GIP1 expression causes growth arrest in tumor cells both in vitro and in vivo, establishing it as a downstream tumor suppressor target of NAC-1.\",\n      \"method\": \"Serial analysis of gene expression (SAGE), siRNA knockdown, ectopic expression, in vitro and in vivo growth assays in SKOV3, HeLa, RK3E, and HEK293 cells\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain/loss-of-function experiments with defined phenotypic readouts, replicated across multiple cell lines\",\n      \"pmids\": [\"17804717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GADD45GIP1, negatively regulated by NAC-1, interacts with GADD45gamma. Knockdown of GADD45GIP1 confers paclitaxel resistance, while ectopic expression increases paclitaxel sensitivity. Disrupting NAC-1 homodimerization induces GADD45gamma expression, which then interacts with GADD45GIP1 to mediate drug sensitivity.\",\n      \"method\": \"shRNA knockdown, ectopic expression, co-immunoprecipitation (interaction with GADD45gamma), ex vivo drug resistance assays in ovarian cancer cell lines and tissues\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain/loss-of-function with Co-IP for binding partner, replicated across cell lines and primary tissues\",\n      \"pmids\": [\"19305429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GADD45GIP1 (CKBBP2/CRIF1) physically associates with the beta subunit of protein kinase CK II (CKII) and is phosphorylated by CKII at serine residue 221. Phosphomimetic mutation S221E promotes cell proliferation, while non-phosphorylatable S221A abrogates CKII-mediated phosphorylation.\",\n      \"method\": \"Yeast two-hybrid, pull-down assay, in vitro kinase assay with purified CKII, phosphoamino acid analysis, site-directed mutagenesis (S221A and S221E), cell proliferation assays in COS7 cells\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstituted kinase assay with mutagenesis validation and functional readout\",\n      \"pmids\": [\"17069992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The CKIIbeta subunit interacts with GADD45GIP1 (CKBBP2); the minimal binding region on CKIIbeta required for this interaction maps to residues 67–130.\",\n      \"method\": \"Yeast two-hybrid system, overlay (far-Western) experiments\",\n      \"journal\": \"Molecules and cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — yeast two-hybrid and overlay assay define interaction domain but lack functional follow-up for CKBBP2 specifically\",\n      \"pmids\": [\"11710515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GADD45GIP1 (CRIF1) is essential for mitochondrial oxidative phosphorylation (OxPhos) complex synthesis and formation in the inner mitochondrial membrane; beta-cell-specific Crif1 knockout mice develop mitochondrial diabetes with progressive beta cell failure, defective insulin secretion, and characteristic mitochondrial ultrastructural abnormalities.\",\n      \"method\": \"Tissue-specific (beta cell) Crif1 knockout mouse model, glucose tolerance tests, insulin secretion assays, electron microscopy for mitochondrial ultrastructure\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with defined cellular and ultrastructural phenotype, multiple orthogonal readouts\",\n      \"pmids\": [\"25660120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Adipocyte-specific deletion of CRIF1/GADD45GIP1 impairs mitochondrial OxPhos in adipocytes, triggering the mitochondrial unfolded protein response and upregulation of mitokines GDF15 and FGF21, which non-cell-autonomously increase systemic energy expenditure and protect against diet-induced obesity. GDF15 specifically regulates energy expenditure in this context.\",\n      \"method\": \"Adipocyte-specific Crif1 knockout mice, RNA sequencing of adipose tissue, pharmacological OxPhos inhibition in 3T3L1 adipocytes, double-knockout mice (AdGKO and AdFKO), metabolic phenotyping\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic models with orthogonal metabolic readouts, identifies downstream mitokine effectors\",\n      \"pmids\": [\"31925461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Drosophila CRIF1 (dCRIF, ortholog of GADD45GIP1) is required for RNAi-mediated gene silencing and siRNA biogenesis; dCRIF interacts with and stabilizes the RNase III enzyme Dicer-2, and loss-of-function mutants show deficient RNAi and impaired antiviral immunity.\",\n      \"method\": \"Drosophila genetic screen, loss-of-function mutant analysis, RNAi efficiency assays, siRNA biogenesis assays, co-immunoprecipitation with Dicer-2\",\n      \"journal\": \"RNA biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with defined molecular phenotype and Co-IP for binding partner, but in Drosophila ortholog only\",\n      \"pmids\": [\"25483042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NAC-1 promotes cisplatin resistance in ovarian cancer by suppressing GADD45GIP1 expression, thereby enabling cisplatin-induced cellular senescence. NAC-1 knockdown increases GADD45GIP1 expression, inhibits cisplatin-induced senescence, and increases cisplatin cytotoxicity; conversely, NAC-1 overexpression in NAC-1-negative cells reduces cisplatin sensitivity via GADD45GIP1 suppression.\",\n      \"method\": \"siRNA knockdown, ectopic overexpression, cellular senescence assays (SA-β-gal), cytotoxicity assays in SKOV3 and TOV-21G ovarian cancer cells\",\n      \"journal\": \"Oncology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain/loss-of-function with defined senescence phenotype, single lab\",\n      \"pmids\": [\"28599472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GADD45GIP1 interacts with ribosomal protein RPL35 and protects it from ubiquitin-mediated proteasomal degradation. Knockdown of GADD45GIP1 reduces RPL35 protein stability and increases RPL35 polyubiquitination; RPL35 depletion activates the PERK/eIF2α pathway, increasing ER stress. Overexpression of RPL35 rescues the decrease in cell viability caused by GADD45GIP1 knockdown in osteosarcoma cells.\",\n      \"method\": \"Immunoprecipitation coupled with LC-MS/MS proteomics, siRNA knockdown, ectopic overexpression, ubiquitination assays, PERK/eIF2α pathway analysis, in vitro and in vivo proliferation/migration assays\",\n      \"journal\": \"Cancer cell international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — IP-MS identifies interactor with functional rescue, multiple assays; single lab, novel finding requiring replication\",\n      \"pmids\": [\"40604925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CRM197 (HB-EGF inhibitor) reverses paclitaxel resistance by downregulating NAC-1, thereby restoring GADD45GIP1 expression; restoration of the GADD45GIP1/Gadd45 pathway activates the JNK/p38MAPK pro-apoptotic pathway and caspase-3 activity in paclitaxel-resistant ovarian cancer cells.\",\n      \"method\": \"In vitro and in vivo drug treatment, siRNA knockdown, Western blotting, caspase-3 activity assays in A2780/Taxol and SKOV3/Taxol cells\",\n      \"journal\": \"Cancer medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — pharmacological and knockdown experiments place GADD45GIP1 in pathway with JNK/p38MAPK; single lab, indirect mechanism\",\n      \"pmids\": [\"31490008\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GADD45GIP1/CRIF1 is a mitochondrial inner membrane protein essential for oxidative phosphorylation complex assembly, whose transcription is repressed by the BTB/POZ factor NAC-1; it interacts with GADD45gamma and RPL35 (protecting RPL35 from ubiquitin-mediated degradation), is phosphorylated by CK II at Ser221 to promote cell proliferation, and its loss triggers mitochondrial stress responses (including mitokine secretion and ER stress via PERK/eIF2α), while its expression in cancer cells induces growth arrest, sensitizes cells to chemotherapy by suppressing senescence-mediated drug resistance, and in Drosophila its ortholog stabilizes Dicer-2 to support RNAi.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries from KEPT papers only.\n\n**Classification:**\n\nRetrieved papers:\n1. PMID:19305429 — KEEP (NAC-1/Gadd45gip1 in ovarian cancer)\n2. PMID:7677843 — EXCLUDE (Aspergillus nidulans penicillin biosynthesis, symbol collision)\n3. PMID:17804717 — KEEP (NAC-1/Gadd45GIP1, tumor suppressor role)\n4. PMID:31925461 — KEEP (Crif1/Gadd45gip1 adipocyte OxPhos)\n5. PMID:25660120 — KEEP (Crif1/Gadd45gip1 beta cell OxPhos)\n6. PMID:31490008 — KEEP (CRM197/NAC-1/Gadd45gip1 paclitaxel resistance)\n7. PMID:17069992 — KEEP (CKBBP2/CRIF1 phosphorylation by CKII)\n8. PMID:11710515 — KEEP (CKBBP2/CRIF1 interaction with CKIIβ)\n9. PMID:28599472 — KEEP (NAC1/GADD45GIP1 cisplatin resistance/senescence)\n10. PMID:25483042 — KEEP (Drosophila CRIF1 ortholog in RNAi/Dicer-2 — ortholog paper)\n11. PMID:40604925 — KEEP (GADD45GIP1/RPL35/ER stress in osteosarcoma)\n12. PMID:41606585 — KEEP (commentary on GADD45GIP1-RPL35 axis)\n\nGene2pubmed additional papers: mostly large-scale interactome/proteome studies. None specifically describe GADD45GIP1 mechanisms — EXCLUDE all as they don't contain specific mechanistic findings about GADD45GIP1.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"GADD45GIP1 (then called CKBBP2) was identified as a binding partner of the CKIIβ regulatory subunit via yeast two-hybrid assay. The minimal binding region on CKIIβ for CKBBP2 was mapped to residues 67–130, distinct from binding sites for other CKIIβ interactors.\",\n      \"method\": \"Yeast two-hybrid mapping with truncation constructs; overlay (far-western) experiments\",\n      \"journal\": \"Molecules and cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single yeast two-hybrid study with domain mapping, single lab\",\n      \"pmids\": [\"11710515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GADD45GIP1 (CKBBP2/CRIF1) physically associates with the CKIIβ subunit and is phosphorylated by protein kinase CKII at serine-221. Phosphomimetic mutation S221E promotes cell proliferation, whereas the non-phosphorylatable S221A mutant does not, establishing CKII-mediated phosphorylation of GADD45GIP1 as a positive regulator of cell proliferation.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, in vitro kinase assay with recombinant CKII, phosphoamino acid analysis, site-directed mutagenesis (S221A and S221E), cell proliferation assay in COS7 cells\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro kinase assay with mutagenesis and functional proliferation readout in cells, multiple orthogonal methods in one study\",\n      \"pmids\": [\"17069992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NAC-1, a BTB/POZ transcription repressor, negatively regulates GADD45GIP1 transcription. NAC-1 knockdown in SKOV3 and HeLa cells induces GADD45GIP1 expression, while NAC-1 overexpression in NAC-1-negative cells suppresses it. Ectopic GADD45GIP1 expression causes growth arrest in tumor cells in vitro and in vivo, and partial rescue of dominant-negative NAC-1-induced growth inhibition by GADD45GIP1 knockdown establishes GADD45GIP1 as a downstream tumor-suppressive effector of the NAC-1 pathway.\",\n      \"method\": \"Serial analysis of gene expression (SAGE), siRNA knockdown, ectopic overexpression, dominant-negative NAC-1, in vitro and in vivo (xenograft) growth assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (SAGE, KD, OE, in vivo), bidirectional epistasis demonstrated\",\n      \"pmids\": [\"17804717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GADD45GIP1 interacts with GADD45γ (growth arrest and DNA-damage-inducible 45-gamma). Loss of GADD45GIP1 confers paclitaxel resistance in ovarian cancer cells, while ectopic GADD45GIP1 expression increases paclitaxel sensitivity. NAC-1 homodimerization suppresses the pathway; disruption of NAC-1 dimerization induces GADD45γ expression, which then interacts with GADD45GIP1, and GADD45γ knockdown partially restores paclitaxel resistance.\",\n      \"method\": \"shRNA knockdown, ectopic expression, dominant-negative BTB/POZ domain construct, ex vivo paclitaxel resistance assays, co-expression epistasis analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional genetic epistasis with multiple cancer cell lines and tissue validation; interaction with GADD45γ established\",\n      \"pmids\": [\"19305429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The Drosophila ortholog of GADD45GIP1/CRIF1 (dCRIF) is required for RNAi efficiency and antiviral immunity. dCRIF loss-of-function mutants are deficient in siRNA biogenesis and RNAi-mediated knockdown. dCRIF physically interacts with and stabilizes the RNase III enzyme Dicer-2, identifying a conserved role for CRIF1 in regulating the RNAi machinery.\",\n      \"method\": \"Drosophila genetic screen, loss-of-function mutants, siRNA biogenesis assays, antiviral immunity assays, co-immunoprecipitation (dCRIF–Dicer-2 interaction)\",\n      \"journal\": \"RNA biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — genetic KO with defined molecular phenotype and Co-IP for interaction, but Drosophila ortholog study\",\n      \"pmids\": [\"25483042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Beta-cell-specific deletion of Crif1 (Gadd45gip1) in mice causes progressive mitochondrial oxidative phosphorylation (OxPhos) dysfunction leading to impaired insulin secretion and beta cell failure, demonstrating that CRIF1 is essential for the synthesis and assembly of OxPhos complexes in the inner mitochondrial membrane of beta cells.\",\n      \"method\": \"Conditional (beta-cell-specific) Crif1 knockout mouse model, glucose tolerance tests, insulin secretion assays, ultrastructural electron microscopy of mitochondria\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean in vivo conditional KO with defined cellular phenotype and ultrastructural validation\",\n      \"pmids\": [\"25660120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NAC1 suppresses GADD45GIP1 expression and promotes cisplatin resistance in ovarian cancer cells by inhibiting cisplatin-induced cellular senescence. NAC1 knockdown increases GADD45GIP1 expression and enhances senescence-dependent cisplatin cytotoxicity, while NAC1 overexpression in NAC1-negative cells reduces cisplatin sensitivity, establishing the NAC1/GADD45GIP1 axis as a regulator of drug-induced senescence.\",\n      \"method\": \"RNA interference (siRNA/shRNA), ectopic overexpression, cisplatin cytotoxicity assays, cellular senescence assays (β-galactosidase staining) in SKOV3 and TOV-21G cells\",\n      \"journal\": \"Oncology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — bidirectional genetic manipulation with defined senescence phenotype, single lab\",\n      \"pmids\": [\"28599472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CRM197, a specific HB-EGF inhibitor, reverses paclitaxel resistance in ovarian cancer cells by downregulating NAC-1, leading to upregulation of GADD45GIP1, which in turn activates the pro-apoptotic JNK/p38 MAPK pathway and increases caspase-3 activity. This positions GADD45GIP1 as a mediator linking NAC-1 suppression to apoptotic signaling.\",\n      \"method\": \"In vitro cell viability assays, in vivo xenograft models, Western blotting for NAC-1/GADD45GIP1/JNK/p38/caspase-3 pathway components\",\n      \"journal\": \"Cancer medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — pathway placement by expression/activity measurements in vitro and in vivo, no direct epistasis rescue\",\n      \"pmids\": [\"31490008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Adipocyte-specific deletion of Crif1 (Gadd45gip1) reduces adipocyte OxPhos function, triggering the mitochondrial unfolded protein response and upregulating secretion of mitokines GDF15 and FGF21. These mitokines mediate systemic metabolic benefits including resistance to diet-induced obesity and improved glucose tolerance, demonstrating that CRIF1 in adipocytes regulates both cell-autonomous and non-cell-autonomous energy homeostasis via mitokine signaling.\",\n      \"method\": \"Adipocyte-specific Crif1 KO mice (AdKO), global Gdf15 and Fgf21 KO crosses (AdGKO, AdFKO), RNA sequencing, metabolic phenotyping (weight, EE, glucose tolerance), pharmacological OxPhos inhibition in 3T3L1 cells\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with multiple orthogonal genetic crosses (AdGKO, AdFKO) establishing pathway hierarchy, replicated in vitro\",\n      \"pmids\": [\"31925461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GADD45GIP1 physically interacts with RPL35 (ribosomal protein L35), identified by co-immunoprecipitation and LC-MS/MS proteomics. GADD45GIP1 stabilizes RPL35 by inhibiting its polyubiquitination and proteasomal degradation. RPL35 knockdown activates the PERK/eIF2α ER stress pathway, and RPL35 overexpression rescues the reduced cell viability caused by GADD45GIP1 knockdown, establishing GADD45GIP1 as a regulator of RPL35 stability that modulates ER stress in osteosarcoma.\",\n      \"method\": \"IP/LC-MS/MS proteomics, siRNA knockdown, overexpression, ubiquitination assay (polyubiquitination), Western blotting for PERK/eIF2α pathway, cell viability and migration assays in vitro and in vivo\",\n      \"journal\": \"Cancer cell international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — IP-MS interaction plus ubiquitination assay and rescue experiment, single lab with multiple methods\",\n      \"pmids\": [\"40604925\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GADD45GIP1/CRIF1 is a multifunctional mitochondrial and nuclear protein: it is essential for the assembly and function of inner mitochondrial membrane oxidative phosphorylation complexes (demonstrated by tissue-specific KO models in beta cells and adipocytes); it is phosphorylated at Ser-221 by protein kinase CKII, promoting cell proliferation; it is transcriptionally repressed by the BTB/POZ factor NAC-1, and its re-expression causes growth arrest and sensitizes tumor cells to paclitaxel and cisplatin by suppressing drug-induced senescence and activating GADD45γ/JNK/p38/caspase-3 apoptotic signaling; and it stabilizes RPL35 against ubiquitin-mediated degradation to modulate ER stress via the PERK/eIF2α pathway.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GADD45GIP1 (also known as CRIF1) is a multifunctional protein that serves as an essential factor for mitochondrial oxidative phosphorylation complex assembly and acts as a growth-suppressive effector in cancer cells. Conditional deletion of GADD45GIP1 in mice disrupts mitochondrial inner membrane OxPhos complexes, leading to tissue-specific metabolic failure—beta-cell dysfunction causing mitochondrial diabetes, or adipocyte mitochondrial stress triggering secretion of mitokines GDF15 and FGF21 that non-cell-autonomously regulate systemic energy expenditure [PMID:25660120, PMID:31925461]. In cancer cells, GADD45GIP1 transcription is repressed by the BTB/POZ factor NAC-1; its re-expression induces growth arrest, interacts with GADD45γ to sensitize cells to paclitaxel and cisplatin through JNK/p38MAPK-mediated apoptosis, and suppresses senescence-driven chemoresistance [PMID:17804717, PMID:19305429, PMID:28599472, PMID:31490008]. GADD45GIP1 is phosphorylated by CK II at Ser221 to promote proliferation, interacts with RPL35 to protect it from ubiquitin-mediated degradation thereby preventing PERK/eIF2α-dependent ER stress, and in Drosophila its ortholog stabilizes Dicer-2 to support siRNA biogenesis and antiviral RNAi [PMID:17069992, PMID:40604925, PMID:25483042].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying GADD45GIP1 as a CK II β-subunit interacting protein established its first known physical interaction and pointed toward regulation by protein kinases.\",\n      \"evidence\": \"Yeast two-hybrid and far-Western overlay mapped the interaction domain on CKIIβ to residues 67–130\",\n      \"pmids\": [\"11710515\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional consequence of CKIIβ binding was not determined\",\n        \"Endogenous interaction not validated by co-immunoprecipitation\",\n        \"Phosphorylation of GADD45GIP1 by CKII not yet tested\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating that CK II phosphorylates GADD45GIP1 at Ser221 and that this phosphorylation promotes cell proliferation resolved how the CKIIβ interaction is functionally consequential.\",\n      \"evidence\": \"In vitro kinase assay with purified CKII, phosphoamino acid analysis, and S221A/S221E mutagenesis with proliferation readouts in COS7 cells\",\n      \"pmids\": [\"17069992\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"In vivo phosphorylation at Ser221 not confirmed in endogenous context\",\n        \"Downstream signaling events of Ser221 phosphorylation unknown\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Establishing GADD45GIP1 as a transcriptional target repressed by NAC-1 and showing that its re-expression causes growth arrest positioned it as a tumor suppressor downstream of a defined oncogenic repressor.\",\n      \"evidence\": \"SAGE profiling, reciprocal siRNA/overexpression of NAC-1 and GADD45GIP1, in vitro and in vivo growth assays across SKOV3, HeLa, RK3E, HEK293 cells\",\n      \"pmids\": [\"17804717\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct versus indirect transcriptional repression mechanism by NAC-1 not distinguished\",\n        \"Growth arrest pathway downstream of GADD45GIP1 not identified\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovering that GADD45GIP1 interacts with GADD45γ and that this axis mediates chemosensitivity to paclitaxel revealed the molecular partnership through which GADD45GIP1 exerts its drug-sensitizing function.\",\n      \"evidence\": \"Co-immunoprecipitation for GADD45γ interaction, shRNA knockdown and ectopic expression, drug resistance assays in ovarian cancer cell lines and primary tissues\",\n      \"pmids\": [\"19305429\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of GADD45GIP1–GADD45γ interaction unknown\",\n        \"Downstream apoptotic pathway not fully mapped at this point\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showing that the Drosophila ortholog stabilizes Dicer-2 and is required for siRNA biogenesis extended the functional repertoire of GADD45GIP1 to RNA interference and innate antiviral immunity.\",\n      \"evidence\": \"Drosophila genetic screen, loss-of-function mutant analysis with RNAi efficiency and siRNA biogenesis assays, co-immunoprecipitation with Dicer-2\",\n      \"pmids\": [\"25483042\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Conservation of Dicer-2 stabilization function in mammalian cells not tested\",\n        \"Mechanism by which dCRIF stabilizes Dicer-2 (e.g., blocking degradation) not defined\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Conditional knockout in mouse beta cells proved that GADD45GIP1 is essential for mitochondrial OxPhos complex assembly in vivo, with its loss causing mitochondrial diabetes—establishing its core mitochondrial function.\",\n      \"evidence\": \"Beta-cell-specific Crif1 knockout mice with glucose tolerance tests, insulin secretion assays, and electron microscopy for mitochondrial ultrastructure\",\n      \"pmids\": [\"25660120\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular mechanism of OxPhos complex insertion/assembly by CRIF1 not elucidated\",\n        \"Which specific OxPhos complexes require CRIF1 for biogenesis not fully resolved in this model\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Linking NAC-1-mediated GADD45GIP1 suppression to cisplatin-induced senescence clarified how GADD45GIP1 silencing enables senescence-dependent chemoresistance, distinct from the paclitaxel resistance mechanism.\",\n      \"evidence\": \"Reciprocal siRNA/overexpression of NAC-1, SA-β-gal senescence assays, cytotoxicity assays in SKOV3 and TOV-21G cells\",\n      \"pmids\": [\"28599472\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct molecular mechanism by which GADD45GIP1 inhibits senescence not identified\",\n        \"Single-lab finding without independent replication\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating that pharmacological restoration of GADD45GIP1 expression activates JNK/p38MAPK and caspase-3 identified the pro-apoptotic signaling cascade downstream of the GADD45GIP1/GADD45γ axis in drug-resistant cells.\",\n      \"evidence\": \"CRM197 treatment to downregulate NAC-1, siRNA validation, caspase-3 activity assays in A2780/Taxol and SKOV3/Taxol cells in vitro and in vivo\",\n      \"pmids\": [\"31490008\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Indirect mechanism through HB-EGF inhibition complicates attribution solely to GADD45GIP1\",\n        \"JNK/p38MAPK activation not shown to be directly triggered by GADD45GIP1–GADD45γ binding\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Adipocyte-specific CRIF1 deletion showed that mitochondrial OxPhos stress triggers non-cell-autonomous metabolic adaptation through mitokines GDF15 and FGF21, broadening GADD45GIP1 function from cell-intrinsic OxPhos to systemic metabolic regulation.\",\n      \"evidence\": \"Adipocyte-specific Crif1 knockout mice, RNA-seq, double-knockout for GDF15/FGF21, comprehensive metabolic phenotyping\",\n      \"pmids\": [\"31925461\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Transcriptional mechanism linking OxPhos deficiency to GDF15/FGF21 upregulation not fully resolved\",\n        \"Whether mitokine response is universal across tissues with CRIF1 loss or adipocyte-specific unknown\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identifying RPL35 as a GADD45GIP1 interactor that is protected from ubiquitin-mediated degradation linked GADD45GIP1 to ribosome homeostasis and ER stress via the PERK/eIF2α pathway.\",\n      \"evidence\": \"IP-MS/MS proteomics, siRNA knockdown, ubiquitination assays, RPL35 overexpression rescue of viability in osteosarcoma cells\",\n      \"pmids\": [\"40604925\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Novel finding from a single lab requiring independent replication\",\n        \"The E3 ubiquitin ligase targeting RPL35 in the absence of GADD45GIP1 is unidentified\",\n        \"Relationship between RPL35 stabilization and the mitochondrial OxPhos function of GADD45GIP1 unclear\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular mechanism by which GADD45GIP1/CRIF1 facilitates OxPhos complex insertion into the mitochondrial inner membrane, and how its nuclear/cytoplasmic functions (GADD45γ binding, RPL35 stabilization, CKII phosphorylation) are coordinated with its mitochondrial role, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model of GADD45GIP1 in complex with OxPhos assembly intermediates\",\n        \"Dual-localization regulation (mitochondrial vs. nuclear/cytoplasmic) not mechanistically dissected\",\n        \"Whether the Dicer-2 stabilization function observed in Drosophila is conserved in mammals is untested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 7, 8]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [4, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 9]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [5, 8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GADD45G\",\n      \"CSNK2B\",\n      \"RPL35\",\n      \"NAC1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"GADD45GIP1 (CRIF1/mL64) is a mitochondrial large ribosomal subunit protein essential for the synthesis and insertion of oxidative phosphorylation (OxPhos) complex subunits into the inner mitochondrial membrane, as demonstrated by conditional knockout models in pancreatic beta cells and adipocytes where its loss causes progressive OxPhos dysfunction, impaired insulin secretion, and compensatory mitokine (GDF15/FGF21) secretion that systemically improves energy homeostasis [PMID:25660120, PMID:31925461]. Beyond its mitochondrial role, GADD45GIP1 functions as a tumor-suppressive effector downstream of the transcriptional repressor NAC-1: its re-expression induces growth arrest, sensitizes ovarian cancer cells to paclitaxel and cisplatin by counteracting drug-induced senescence, and activates GADD45γ-dependent JNK/p38/caspase-3 apoptotic signaling [PMID:17804717, PMID:19305429, PMID:31490008]. GADD45GIP1 is phosphorylated by casein kinase II at Ser-221, and the phosphomimetic S221E mutant promotes cell proliferation, indicating context-dependent regulation of growth [PMID:17069992]. GADD45GIP1 also stabilizes the ribosomal protein RPL35 by inhibiting its polyubiquitination, thereby modulating PERK/eIF2α-mediated ER stress signaling [PMID:40604925].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of GADD45GIP1 as a physical interactor of the CKIIβ regulatory subunit established it as a potential signaling target of the CKII kinase, opening the question of whether CKII phosphorylates it and with what functional consequence.\",\n      \"evidence\": \"Yeast two-hybrid screen and far-western overlay mapping the CKIIβ binding region\",\n      \"pmids\": [\"11710515\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single yeast two-hybrid study without in vivo validation of the interaction\",\n        \"Phosphorylation and functional relevance not yet tested\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstration that CKII phosphorylates GADD45GIP1 at Ser-221 and that this modification promotes cell proliferation resolved the functional consequence of the CKII interaction, establishing GADD45GIP1 as a growth-regulatory phosphoprotein.\",\n      \"evidence\": \"In vitro kinase assay, phosphoamino acid analysis, S221A/S221E mutagenesis with proliferation readout in COS7 cells\",\n      \"pmids\": [\"17069992\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"In vivo relevance of Ser-221 phosphorylation not tested\",\n        \"Downstream effectors of phospho-GADD45GIP1-driven proliferation not identified\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovery that the BTB/POZ repressor NAC-1 transcriptionally silences GADD45GIP1, and that restoring GADD45GIP1 expression causes tumor growth arrest in vitro and in vivo, established GADD45GIP1 as a bona fide tumor-suppressive effector in the NAC-1 oncogenic pathway.\",\n      \"evidence\": \"SAGE, siRNA/overexpression epistasis, xenograft growth assays in SKOV3 and HeLa cells\",\n      \"pmids\": [\"17804717\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which GADD45GIP1 enforces growth arrest not defined\",\n        \"Whether NAC-1 directly binds the GADD45GIP1 promoter not shown\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linking GADD45GIP1 to GADD45γ interaction and showing that this axis mediates paclitaxel sensitivity upon disruption of NAC-1 dimerization revealed the downstream apoptotic effector mechanism through which GADD45GIP1 sensitizes tumor cells to chemotherapy.\",\n      \"evidence\": \"Bidirectional genetic epistasis (shRNA, ectopic expression, dominant-negative BTB domain) with paclitaxel resistance assays in ovarian cancer cells\",\n      \"pmids\": [\"19305429\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of GADD45GIP1–GADD45γ interaction unknown\",\n        \"Whether GADD45GIP1 directly participates in MAPK cascade activation not resolved\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of the Drosophila ortholog dCRIF as essential for Dicer-2 stability and siRNA biogenesis broadened the functional repertoire of CRIF1 family proteins to include regulation of the RNAi machinery and antiviral defense.\",\n      \"evidence\": \"Drosophila genetic screen with loss-of-function mutants, siRNA biogenesis assays, co-immunoprecipitation of dCRIF–Dicer-2\",\n      \"pmids\": [\"25483042\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Conservation of the Dicer-2-stabilizing function in mammalian GADD45GIP1 not tested\",\n        \"Mechanism of stabilization (chaperone-like vs. stoichiometric protection) not determined\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Beta-cell-specific Crif1 knockout demonstrated that GADD45GIP1 is essential for mitochondrial OxPhos complex assembly, resolving the primary cell-autonomous function of the protein in energy metabolism and linking its loss to beta cell failure and impaired insulin secretion.\",\n      \"evidence\": \"Conditional Crif1 KO mouse, glucose tolerance and insulin secretion assays, electron microscopy of mitochondrial ultrastructure\",\n      \"pmids\": [\"25660120\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific OxPhos complex subunits whose insertion depends on CRIF1 not individually mapped\",\n        \"Whether CRIF1 acts co-translationally at the mitoribosome or post-translationally not distinguished\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Establishing that NAC1 promotes cisplatin resistance by suppressing GADD45GIP1 and thereby blocking drug-induced senescence expanded the tumor-suppressive role of GADD45GIP1 from paclitaxel to platinum-based chemotherapy and identified cellular senescence as a key effector phenotype.\",\n      \"evidence\": \"siRNA/shRNA and overexpression in SKOV3 and TOV-21G cells, cisplatin cytotoxicity and β-galactosidase senescence assays\",\n      \"pmids\": [\"28599472\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab study; independent replication in additional cell lines or models needed\",\n        \"Molecular mechanism linking GADD45GIP1 to senescence induction not defined\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Placement of GADD45GIP1 as the mediator connecting NAC-1 downregulation (by CRM197) to JNK/p38 MAPK activation and caspase-3-dependent apoptosis completed the signaling cascade from NAC-1 repression through GADD45GIP1 to cell death.\",\n      \"evidence\": \"CRM197 treatment in vitro and in vivo xenograft models, Western blotting of NAC-1/GADD45GIP1/JNK/p38/caspase-3 pathway\",\n      \"pmids\": [\"31490008\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No direct epistasis rescue experiment to confirm GADD45GIP1 is required downstream of CRM197\",\n        \"Pathway placement relies on expression/activity correlations\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Adipocyte-specific Crif1 deletion demonstrated that CRIF1 loss triggers the mitochondrial unfolded protein response and non-cell-autonomous metabolic benefits via GDF15 and FGF21 mitokine secretion, revealing a systemic endocrine signaling axis controlled by mitochondrial OxPhos fidelity.\",\n      \"evidence\": \"Adipocyte-specific Crif1 KO mice crossed with global Gdf15-KO and Fgf21-KO, RNA-seq, metabolic phenotyping, pharmacological OxPhos inhibition in 3T3-L1 cells\",\n      \"pmids\": [\"31925461\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the metabolic benefit is durable long-term or represents a compensatory acute response is not fully resolved\",\n        \"Direct mechanism linking mitochondrial UPR to GDF15/FGF21 transcriptional activation not defined\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery that GADD45GIP1 stabilizes RPL35 by blocking its polyubiquitination and that RPL35 loss activates PERK/eIF2α ER stress uncovered a previously unrecognized function of GADD45GIP1 in ribosomal protein quality control and ER stress modulation.\",\n      \"evidence\": \"IP/LC-MS/MS proteomics, ubiquitination assays, siRNA knockdown and overexpression rescue, PERK/eIF2α Western blotting in osteosarcoma cells\",\n      \"pmids\": [\"40604925\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab study; awaits independent confirmation in non-cancer cell types\",\n        \"E3 ubiquitin ligase targeting RPL35 not identified\",\n        \"Relationship between GADD45GIP1's mitoribosomal role and its cytoplasmic RPL35-stabilizing function unclear\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Whether GADD45GIP1/CRIF1 acts co-translationally at the mitoribosome to insert OxPhos subunits versus as a post-translational chaperone, how its nuclear/cytoplasmic tumor-suppressive functions are coordinated with its mitochondrial role, and the structural basis for its diverse protein–protein interactions remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model of GADD45GIP1 in context of the mitoribosome or any partner complex\",\n        \"Mechanism of dual localization (mitochondrial vs. nuclear) and how it is regulated is unknown\",\n        \"Whether the Dicer-2/RNAi role observed in Drosophila is conserved in mammals is untested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 3, 6, 7, 9]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [5, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [5, 8]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [5, 8]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [3, 7]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 7]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [8, 9]}\n    ],\n    \"complexes\": [\n      \"mitochondrial large ribosomal subunit (39S)\"\n    ],\n    \"partners\": [\n      \"CSNK2B\",\n      \"GADD45G\",\n      \"NACC1\",\n      \"RPL35\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}